Related Experiment Video
Updated: May 11, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Waldenström macroglobulinaemia: the key questions
Anita D'Souza1, Stephen Ansell, Craig Reeder
1Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
British Journal of Haematology
|May 9, 2013
Abstract:
In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.
